Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.076 AUD | -2.56% | -5.00% | -6.17% |
03-20 | Australia's Tax Agency Publishes Ruling on Invex Therapeutics' Capital Return | MT |
02-16 | Invex Therapeutics Narrows Fiscal H1 Loss on Lower R&D Expenses | MT |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Narelle Warren
DFI | Director of Finance/CFO | - | 28/02/19 |
Carol Parish
COO | Chief Operating Officer | - | - |
Thomas Duthy
BRD | Director/Board Member | - | 30/09/20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David McAuliffe
CHM | Chairman | 58 | 07/03/19 |
Narelle Warren
DFI | Director of Finance/CFO | - | 28/02/19 |
Thomas Duthy
BRD | Director/Board Member | - | 30/09/20 |
Megan Baldwin
BRD | Director/Board Member | 49 | 15/02/21 |
David Wheeler
BRD | Director/Board Member | 65 | 11-07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 75,153,848 | 30,220,477 ( 40.21 %) | 0 | 40.21 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-6.17% | 3.87M | |
+26.01% | 44.96B | |
+0.22% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+10.50% | 26.08B | |
-20.96% | 19.03B | |
+6.75% | 12.75B | |
+28.81% | 12.06B | |
-3.78% | 11.75B |
- Stock Market
- Equities
- IXC Stock
- Company Invex Therapeutics Ltd